Key result
Rheumatoid arthritis is linked to a non-fatal MI risk comparable to type 2 diabetes.
Why the study?
Patients with rheumatoid arthritis have a higher risk of cardiovascular diseases but receive less cardiovascular screening attention compared to diabetes mellitus patients.
Does rheumatoid arthritis confer a similar risk of myocardial infarction compared to type 2 diabetes mellitus?
Cohort (n=750)
Yes
Does rheumatoid arthritis confer a similar risk of myocardial infarction compared to type 2 diabetes mellitus?
Relative Risk: 0.93 (95% CI 0.58–1.58)
Absolute Event Rate: 12.66% vs 13.48%
p-value: p=0.79
Rheumatoid arthritis confers a risk of cardiovascular events comparable to type 2 diabetes mellitus, highlighting the need for aggressive cardiovascular screening and multidisciplinary management in RA patients.
Introduction Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular diseases (CVDs) when compared to the general population, with most deaths attributed to myocardial infarctions (MI). However, patients with RA do not get the same attention in terms of cardiovascular screening as compared to other diseases, like diabetes mellitus (DM). Therefore, this study aims to compare the risk of CVD among patients with RA and DM. Methods This prospective study was carried out in Pakistan's two tertiary care hospitals. A total of 750 participants were enrolled in three groups with a 1:1:1 ratio; patients with RA, type 2 DM, and the control group. Patients were observed for 12 months or until the development of a major adverse cardiovascular event (MACE), whichever occurred first. Results Both fatal (12.66% vs. 13.48%; p-value: 0.79) and non-fatal (3.93% vs. 4.35%; p-value: 0.82) MI was comparable between both RA and DM group. However, compared to the control group, non-fatal MI (12.66% vs. 5.58%; p-value: 0.01) was significantly higher in the RA group. Conclusion Our study shows that RA and DM have an equal risk of cardiovascular (CV) events. It is important that RA should be considered as a prominent risk factor for CV events. The management of these patients should be multidisciplinary, including cardiologists.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2021) conducted a cohort in Rheumatoid Arthritis and Type 2 Diabetes Mellitus (n=750). Rheumatoid arthritis vs. Type 2 diabetes mellitus was evaluated on Non-fatal myocardial infarction (RR 0.93, 95% CI 0.58-1.58, p=0.79). Patients with rheumatoid arthritis had a comparable risk of non-fatal myocardial infarction to those with type 2 diabetes mellitus (12.66% vs 13.48%, RR 0.93), but a significantly higher risk than healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: